-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Tochino Y; Department of Hematology/Oncology, Wakayama Medical University.; Department of Hematology, Kinan Hospital., Mushino T; Department of Hematology/Oncology, Wakayama Medical University.; Department of Hematology, Kinan Hospital., Hori Y; Department of Hematology/Oncology, Wakayama Medical University.; Department of Hematology, Kinan Hospital.; Department of Internal Medicine, Kinan Hospital., Miyamoto Y; Department of Cardiology, Kinan Hospital., Miyamoto M; Department of Cardiology, Kinan Hospital., Koyama A; Departmentof Central Clinical Laboratory, Kinan Hospital., Shiotani C; Departmentof Central Clinical Laboratory, Kinan Hospital., Hirayasu K; Department of Clinical Laboratory, Wakayama Medical University Hospital., Minoura N; Department of Clinical Laboratory, Wakayama Medical University Hospital., Tamura S; Department of Hematology/Oncology, Wakayama Medical University.; Department of Hematology, Kinan Hospital., Nakano Y; Department of Internal Medicine, Kinan Hospital., Sonoki T; Department of Hematology/Oncology, Wakayama Medical University.
المصدر: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2020; Vol. 61 (12), pp. 1660-1666.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN: 0485-1439 (Print) Linking ISSN: 04851439 NLM ISO Abbreviation: Rinsho Ketsueki Subsets: MEDLINE
مواضيع طبية MeSH: Factor V/*antagonists & inhibitors, Aged ; Factor Xa Inhibitors/adverse effects ; Humans ; Male ; Percutaneous Coronary Intervention ; Pyrazoles/adverse effects ; Pyridones/adverse effects